Serum lipids and tissue DNA content in Egyptian female breast cancer patients

Japanese Journal of Clinical Oncology

Volumn 33, Issue 6, 2003, Pages 278-282

  Abu Bedair, Farid Ahmed ^a   El Gamal, Basiouny Ahmed ^b   Ibrahim, Nagi Ali ^c   El Aaser, Abdelbaset Anwer ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b Alexandria University Faculty Of Science   (Egypt)

^c Zagazig University   (Egypt)

Author keywords

Breast cancer; Serum lipids; Tumor DNA content

Indexed keywords

CHOLESTEROL; DNA; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER PATIENT; CANCER RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EGYPT; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN TISSUE; LIPID BLOOD LEVEL; LUTEAL PHASE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; BREAST TUMOR; CANCER STAGING; CHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; BREAST NEOPLASMS; CHOLESTEROL; DNA, NEOPLASM; FEMALE; HUMANS; LIPIDS; MIDDLE AGED; NEOPLASM STAGING; POSTMENOPAUSE; PREMENOPAUSE; TRIGLYCERIDES;

EID: 0042785846     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyg059     Document Type: Article

References (38)

1. Ibrahim AS. Breast Cancer: Epidemiology and risk factors. J Egypt Natl Cancer Inst 1982;1:13-25.
2. Gillet CE, Happerfield LC. Breast cancer - from clinic to laboratory. Br J Biomed Sci 1997;54:47-56.
3. Henerson MM. Nutritional aspects of breast cancer. Cancer 1995;76: 2053-8.
4. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Cancer Epidemiol Res 1993;15:36-47.
5. Lai LC. Metabolism of dehydroepiandrosterone sulfate by breast cysts: possible role in the development of breast cancer. Cancer Detect Prev 1995;19:441-5.
6. Abu-Bedair FA, El-Gamal BA, Ibrahim NA, El-Aaser AA. Hormonal profiles and estrogen receptors in Egyptian female breast cancer patients. Tumori 2000;86:24-9.
7. Thomas HV, Key TJ, Allen DS, Moore SW, Fentiman IS, Wang DY, et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in postmenopausal women on the island of Guernsey. Br J Cancer 1997;76:401-5.
8. Zeleniuch-Jacquotte A, Bruning PF, Bonfrer JMG, Koening KL, Shore RE, Kim MY, et al. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am J Epidemiol 1997;145:1030-8.
9. Moysich KB, Freudenheim JL, Baker JA, Ambroson CB, Bowman ED, Schisterman EF, et al. Apolipoprotein E genetic polymorphism, serum lipoproteins, and breast cancer risk. Mol Carcinog 2000;27:2-9.
10. Luo S, Labrie C, Belanger A, Labrie F. Serum lipids, and dimethylbenz(a)anthracene-induced mammary carcinoma in the rat. Effect of dehydroepiandrosterone on bone mass. Endocrinology 1997;138:3387-94.
11. Luo S, Sourla A, Labrie C, Belanger A, Labrie F. Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A) anthracene-induced mammary carcinoma in the rat. Endocrinology 1997;138:4435-44.
12. Gooden PJ, Boyd NF, Hanna W, Hartwick W, Murray D, Qizilbash A, et al. Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr Cancer 1997;27: 284-92.
13. Vrbanec D, Reiner Z, Belev B, Plestina S. Changes in serum lipid and lipoprotein levels in postmenopausal patients with node-positive breast cancer treated with tamoxifen. Tumori 1998;84:687-90.
14. Elkhadrawy TG, Ashan H, Nrugut AI. Serum cholesterol and the risk of duct in situ: A case-control study. Eur J Cancer Prev 1998;7:394-6.
15. Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, Tryggvadottir L. Cancer Epidemiol 1997;6:863-73.
16. Fallenius AG, Franzen SA, Auer GU. Predictive value of nuclear DNA content in breast cancer. Cancer 1988;62:521-30.
17. Nishi J, Okajima K, Rayo T, Sekimoto T. Clinical significance of measurement of nuclear DNA content in breast cancer. J Japanese Surg Soc 1989;90:1559-63.
18. Shiao YH, Chen VW, Lehmann HP, Wu XC, Correa P. Patterns of DNA ploidy and S-phase associated with breast cancer survival in blacks and whites. Clin Cancer Res 1997;3:587-92.
19. Moran RE, Black MM, Alpert L, Straus M. Correlation of cell-cycle kinetics hormone receptors, histopathology, and nodal status human breast cancer. Cancer 1984;54:1586-9.
20. Gentili C, Sanfilippo O, Silverstrini R. Cell proliferation and its relationship to clinical features. Cancer 1981;48:947-79.
21. Knight JA, Anderson S, Rawlem JM. Estimation of total lipids in serum and tissues. Clin Chem 1972;18:199-201.
22. Allain LA, Poon LS, Chan LSG, Richmond W, Fu PL. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
23. McGowan MW, Artiss JD, Strandbergh DR, Zak BA. Peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 1983;29:538-42.
24. Melmed RN, El-Aaser AA, Holt SJ. Hypertrophy and hyperplasia of neonatal rat. Biochemistry 1976;421:280-8.
25. Basil IA, Williams PS, Dickerson JWT. Plasma lipids and prolactin in patients with breast cancer. Br J Cancer 1986;54:439-46.
26. Basu TK, Williams DC. Plasma and body lipids in patients with carcinoma of the breast. Oncology 1975;31:172-5.
27. Gaard M, Tretli S, Urdal P. Risk of breast cancer in relation to blood lipids: A prospective study of 31,209 Norwegian women. Cancer Causes Control 1994;5:501-9.
28. Kokoglu E, Karaarslan I, Karaarslan HM, Baloglu H. Alterations of serum lipids and lipoproteins in breast cancer. Cancer Lett 1994;82:175-8.
29. Qi XZ, Zhang AY, Wu GL, Pang WZ. The association between breast cancer and diet and other factors. Asia Pac J Public Health 1994;7:98-104.
30. Dziewulska-Bokiniec A, Wojtacki J, Skokowski J, Kortas B. The effect of tamoxifen treatment on serum cholesterol fractions in breast cancer women. Neoplasma 1994;41:13-6.
31. Tartter PI, Papatestas AE, Ioannovich J, Mulvihill MN, Lesnick G, Aufses AH. Cholesterol and obesity as prognostic factors in breast cancer. Cancer 1981;47:2222-6.
32. Zielinski CC, Stuller I, Ransch P, Muller C. Increased serum concentrations of cholesterol and triglycerides in the progression of breast cancer. Cancer Res Clin Oncol 1988;114:514-8.
33. Wu AH. Diet and breast carcinoma in multiethnic populations. Cancer Supp 2000;88:1239-44.
34. Namura A, Henderson BE, Lee J. Breast cancer and diet among the Japanese in Hawaii. Am J Clin Nut 1987;31:2020-7.
35. Meade CJ, Mertin J. Fatty acids and immunity. Advances Lipid Res 1978; 16:127-30.
36. Gwynne JT, Strauss JF. The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands. Endocrin Rev 1982;3: 299-329.
37. Stenkvist D, Bengtsson E, Nordin B. Histopathology and cytometry in prognosis of breast cancer. J Clin Pathol 1984;36:392-8.
38. Meyer JD, Friedman E, McCrate MM, Bauer WC. Prediction of early course of breast carcinoma by the thymidine labeling. Cancer 1993;51: 1879-86.